ABOUT DICLOFENAC SODIUM

Gastrointestinal (GI): NSAIDs that block COX-1 action have correlations with GI troubles due to inhibition on the synthesis of gastroprotective brokers including PGE2 and other prostaglandins. This inhibition brings about decreased mucin manufacturing by gastric epithelial cells, much less bicarbonate secretion, and fewer epithelial cell turnover,